Podcasts about live talks

After Deborah Kan's mother, Alvera Kan, died in December of last year, the family donated her brain to UCSF to better understand what type of dementia she had. The answer came back with not just one diagnosis, but three different types of dementia: Alzheimer's disease, vascular dementia, and LATE. Kan and her sister, Susan Whitaker, are joined by Dr. Bruce Miller, director of the UCSF Edward and Pearl Fein Memory and Aging Center, and Dr. David Soleimani-Meigooni, a neurologist at UCSF's Memory and Aging Center and assistant professor focused on precision diagnosis in Alzheimer's and related neurodegenerative diseases. Miller's work has helped shape how clinicians identify and distinguish different forms of dementia, including frontotemporal dementia, while Soleimani-Meigooni's clinical and research work includes using imaging and biomarkers to better understand amyloid, tau and other drivers of cognitive decline.In this conversation with Kan and Whitaker, Miller and Soleimani-Meigooni discuss how dementia diagnosis can remain uncertain during life and how an autopsy can reveal multiple diseases. They underscores how common mixed dementias are, why symptoms such as getting lost or struggling with numbers can point to specific brain changes, and why better diagnostic tools are needed. They also highlight the lasting scientific value of brain donation, showing how one family's decision can contribute to more precise diagnoses, better biomarkers, and, ultimately, more individualized treatment approaches for future patients.---If you loved listening to this Live Talk, visit our website to find more of our Alzheimer's coverage and subscribe to our newsletter: https://www.beingpatient.com/Follow Being Patient: Twitter: https://twitter.com/Being_Patient_Instagram: https://www.instagram.com/beingpatientvoices/Facebook: https://www.facebook.com/beingpatientalzheimersLinkedIn: https://www.linkedin.com/company/being-patientBeing Patient is an editorially independent journalism outlet for news and reporting about brain health, cognitive science, and neurodegenerative diseases. In our Live Talk series on Facebook, former Wall Street Journal Editor and founder of Being Patient, Deborah Kan, interviews brain health experts and people living with dementia. Check out our latest Live Talks: https://beingpatient.com/live-talks/

Dr. Michael Fossel, MD, PhD is a physician-scientist and recognized expert in aging and telomere biology. He serves as chairman of the board of Telocyte, a biotech company developing telomerase therapy for Alzheimer's disease, with FDA-sponsored human trials planned to target the underlying disease process. Fossel has authored more than 100 scientific publications and has lectured internationally, including at the National Institutes of Health. His work explores how processes like cell senescence — when aging cells stop working properly and can contribute to chronic inflammation — may help drive age-related diseases, including Alzheimer's.In the interview with Being Patient Founder Deborah Kan, Fossel argues that aging is not simply wear and tear, but a breakdown in the body's ability to maintain and repair cells over time. He explains why lifestyle habits may help slow aging but are unlikely to reset it and outlines why his research is focused on whether telomerase therapy could restore cellular function in Alzheimer's. He acknowledges that the science is still in its early stages, with major questions remaining about how much damage can be reversed, which patients might benefit most, and how soon these ideas can be tested in people.----If you loved listening to this Live Talk, visit our website to find more of our Alzheimer's coverage and subscribe to our newsletter: https://www.beingpatient.com/Follow Being Patient: Twitter:   / being_patient_  Instagram:   / beingpatientvoices  Facebook:   / beingpatientalzheimers  LinkedIn:   / being-patient  Being Patient is an editorially independent journalism outlet for news and reporting about brain health, cognitive science, and neurodegenerative diseases. In our Live Talk series on Facebook, former Wall Street Journal Editor and founder of Being Patient, Deborah Kan, interviews brain health experts and people living with dementia. Check out our latest Live Talks: https://beingpatient.com/live-talks/

Conversations about cognitive impairment can feel confusing and hard to navigate. You may notice small changes and not know whether to bring it up, how to bring it up, or what the “right” approach is without causing fear, defensiveness, or shame. Dr. Dani Cabral is a neurologist and psychiatrist with more than 15 years of experience in Alzheimer's care and clinical research. She founded BrainLove after seeing how the traditional health care system often fails to give patients and families the time, support, and individualized care they need. Through BrainLove, Cabral is working to transform the narrative on Alzheimer's and related diseases by combining cutting-edge medical care, accessible education, and trusted resources to help families move forward with more clarity and a sense of possibility. Drawing on her background in both neurology and psychiatry, as well as early experience in hospice dementia care, Cabral brings a whole-person approach that addresses not only the biology of cognitive decline, but also the emotional, psychological, and practical realities families face.In this interview with Being Patient's Mark Niu, Cabral emphasizes that conversations about cognitive changes should begin gently and without assumptions, focusing on curiosity rather than confrontation. She highlights the importance of involving family members early, addressing safety concerns before they become crises, and recognizing that cognitive decline is not always straightforward or caused by one condition alone. --- If you loved watching this Live Talk, visit our website to find more of our Alzheimer's coverage and subscribe to our newsletter: https://www.beingpatient.com/Follow Being Patient: Twitter: https://twitter.com/Being_Patient_Instagram: https://www.instagram.com/beingpatientvoices/Facebook: https://www.facebook.com/beingpatientalzheimersLinkedIn: https://www.linkedin.com/company/being-patientBeing Patient is an editorially independent journalism outlet for news and reporting about brain health, cognitive science, and neurodegenerative diseases. In our Live Talk series on Facebook, former Wall Street Journal Editor and founder of Being Patient, Deborah Kan, interviews brain health experts and people living with dementia. Check out our latest Live Talks: https://beingpatient.com/live-talks/

This interview is brought to you in partnership with Eisai and is part of the Journey to Diagnosis series.Eisai: https://www.eisai.com/index.htmlJourney to Diagnosis: https://beingpatient.com/journey-to-diagnosis/Ben Draper was just 47 when he was diagnosed with early-onset Alzheimer's. In the years leading up to that diagnosis, he and his wife, Robin, began noticing changes. Ben struggled with everyday tasks that used to come easily, such as sending text messages, using a phone or computer, managing time, and doing simple math. While running his construction business, he realized he could no longer read a tape measure. Even following GPS while driving became difficult.Early testing revealed significant cognitive impairment, followed by an extensive medical workup that included an MRI and a spinal tap. The results showed amyloid plaque, and, with a strong family history of Alzheimer's, Ben later learned he also carries a genetic link to the disease.Today, Ben and Robin are focused on living each day to the fullest. They document their experiences on TikTok (@draperfamilylife) to help others feel less alone and to raise awareness about early-onset Alzheimer's.In this conversation with Being Patient's founder Deborah Kan, Ben and Robin describe the emotional whiplash of fearing a rapidly fatal diagnosis like Creutzfeldt-Jakob disease before receiving clarity, and the unexpected relief that can come with finally having the early-onset Alzheimer's diagnosis. They talk candidly about Ben's symptoms and how financial and care gaps can leave younger families scrambling for disability coverage, insurance, and support. Above all, they return to a guiding mindset, focus on what Ben can still do, lean on community, and make each day count.----Visit Being Patient for more Alzheimer's and brain health coverage: https://www.beingpatient.com/Follow Being PatientTwitter: https://twitter.com/Being_PatientInstagram: https://www.instagram.com/beingpatientvoices/Facebook: https://www.facebook.com/beingpatientalzheimersLinkedIn: https://www.linkedin.com/company/being-patientBeing Patient is an editorially independent journalism outlet covering brain health, cognitive science, and neurodegenerative diseases. Our Live Talk series features interviews with experts and people living with dementia.Watch more Live Talks: https://beingpatient.com/live-talks/

Parkinson's can affect speech and swallowing—often starting with subtle changes like a softer or raspy voice. Without treatment, these issues can progress, making communication harder and increasing the risk of swallowing complications, including aspiration.In this Live Talk, Samantha Elandary, MA, CCC-SLP—speech-language pathologist and President & CEO of the Parkinson Voice Project—shares why early evaluation matters and how targeted therapy can help people protect their voice and swallow. She explains how Parkinson's can change how loud someone thinks they're speaking, why everyday skills like talking and swallowing may need to shift from “automatic” to more intentional control, and how daily practice can make a difference.You'll learn about:Early signs of Parkinson's-related voice and speech changesWhy “speaking with intent” can support clearer communicationHow speech therapy may help protect swallowing and reduce aspiration riskWhy consistent at-home exercises are key (not just clinic visits)Programs like Parkinson Voice Project's SPEAK OUT!® and ongoing supportExplore more brain health journalism from Being Patient + subscribe to our newsletter:https://www.beingpatient.com/Follow Being PatientTwitter:   / being_patient_  Instagram:   / beingpatientvoices  Facebook:   / beingpatientalzheimers  LinkedIn:   / being-patient  Being Patient is an editorially independent journalism outlet covering brain health, cognitive science, and neurodegenerative diseases. In our Live Talk series, founder and former Wall Street Journal editor Deborah Kan interviews experts and people with lived experience.Watch our latest Live Talks:https://beingpatient.com/live-talks/

Exercise can ease Parkinson's symptoms — but can it also slow the disease itself?In this Being Patient Live Talk, Northwestern University researcher Daniel Corcos, PhD breaks down the science behind high-intensity aerobic exercise and why his team is putting it to the test in a major Phase 3 clinical trial (SPARX3). SPARX3 is designed to examine whether exercise intensity can influence Parkinson's progression, especially for people who are newly diagnosed and not yet taking Parkinson's medication.Corcos, a professor in Northwestern's Department of Physical Therapy and Human Movement Sciences, shares what research has already taught us about exercise and Parkinson's — and what we still need to prove. He also lays out a practical, four-part “exercise prescription” you can use as a framework:✅ Aerobic training✅ Resistance/strength work✅ Flexibility✅ Balance + neuromotor trainingYou'll also learn how SPARX3 will follow 370 participants over two years, comparing moderate- vs. high-intensity treadmill training and tracking changes in symptoms and brain imaging to explore whether higher intensity is linked to slower progression.Hosted by: Deborah Kan, Founder of Being Patient--- Subscribe for more Live Talks and brain health reporting:https://www.beingpatient.com/Follow Being Patient:Twitter/X:   / being_patient  Instagram:   / beingpatientvoices  Facebook:   / beingpatientalzheimers  LinkedIn:   / being-patient  Watch more Live Talks:https://beingpatient.com/live-talks/Being Patient is an editorially independent journalism outlet covering brain health, cognitive science, and neurodegenerative diseases. In our Live Talk series, founder and former Wall Street Journal editor Deborah Kan interviews brain health experts and people living with dementia.#parkinsonsdisease #Exercise #SPARX3 #BrainHealth #Neurology #ParkinsonsResearch #Fitness #MovementDisorder #BeingPatient

High blood pressure is one of the most common and treatable risk factors for cognitive decline, and researchers are still working to understand exactly how it affects the brain. A preclinical study from Weill Cornell Medicine, published in Neuron, suggests hypertension may trigger early gene expression changes in the brain, affecting neurons, blood vessels, and white matter before there's any measurable rise in blood pressure.Dr. Costantino Iadecola, the study's senior author, is a neurologist and the director of the Feil Family Brain and Mind Research Institute at Weill Cornell Medicine. His research examines how brain blood vessels support cognition and what happens when that system is disrupted by vascular risk factors like hypertension.In this interview with Being Patient's Mark Niu, Iadecola explains that in a controlled mouse model, researchers saw changes in blood vessels within days of triggering hypertension. He notes that high blood pressure is part of a broader process that can quietly affect multiple organs, including the brain, before obvious symptoms appear. He also discusses why controlling blood pressure dramatically reduces stroke risk but may not lower dementia risk as much as hoped, suggesting prevention may need to start earlier and be more individualized. For now, he emphasizes improving diet, staying active, and taking medication when appropriate to manage blood pressure. If you loved listening to this Live Talk, visit our website to find more of our Alzheimer's coverage and subscribe to our newsletter: https://www.beingpatient.com/Follow Being Patient: Twitter:   / being_patient_  Instagram:   / beingpatientvoices  Facebook:   / beingpatientalzheimers  LinkedIn:   / being-patient  Being Patient is an editorially independent journalism outlet for news and reporting about brain health, cognitive science, and neurodegenerative diseases. In our Live Talk series on Facebook, former Wall Street Journal Editor and founder of Being Patient, Deborah Kan, interviews brain health experts and people living with dementia. Check out our latest Live Talks: https://beingpatient.com/live-talks/

AI-ul nu mai e tool. E creator. Dar cine e autorul? Cine e responsabil? Și unde mai încape omul?Marian Hurducaș discută în această ediție despre artiști digitali (Lolita Cercel), roboți care colaborează între ei (Moltbook) și viitorul creației cu Alin Popescu, fondator avocatnet.ro și fost "avocat de digital" pe vremea când internetul trebuia explicat.Upgrade 100 Live Talks se aude în fiecare luni, după 19:00, la RADIO GUERRILLA. În variantă podcast după, pe upgrade100.live.

Older adults often turn to prescription and over-the-counter sleep aids — but what do we really know about their long-term effects on brain health? A large, long-running UCSF study, published in the Journal of Alzheimer's Disease, examined the association between sleep medication use and risk of dementia in older adults. Researchers found that frequent use of sleep medications was linked to a higher likelihood of developing dementia among white participants, while the same pattern was not seen among Black participants. Dr. Yue Leng, PhD, an epidemiologist at UC San Francisco whose work explores how sleep, circadian rhythms, and napping relate to neurodegeneration and cognitive decline in older adults, was one of the researchers on the study.If you loved listening this Live Talk, visit our website to find more of our Alzheimer's coverage and subscribe to our newsletter: https://www.beingpatient.com/Follow Being Patient: Twitter: https://twitter.com/Being_Patient_Instagram: https://www.instagram.com/beingpatientvoices/Facebook: https://www.facebook.com/beingpatientalzheimersLinkedIn: https://www.linkedin.com/company/being-patientBeing Patient is an editorially independent journalism outlet for news and reporting about brain health, cognitive science, and neurodegenerative diseases. In our Live Talk series on Facebook, former Wall Street Journal Editor and founder of Being Patient, Deborah Kan, interviews brain health experts and people living with dementia. Check out our latest Live Talks: https://beingpatient.com/live-talks/

Can your brain's “anti-reward” system sabotage motivation — and can you train it to work for you instead of against you?In this Live Talk, Being Patient founder Deborah Kan sits down with Dr. Kyra Bobinet, physician, public health leader, and behavior expert, to explain the science of the habenula — a tiny brain structure with an outsized role in motivation, habits, cravings, stress, and setbacks.Dr. Bobinet describes the habenula as an “anti-reward” hub that can overpower dopamine pathways when it flips on in response to perceived failure, fueling frustration, shame, and negative self-talk. She shares a practical framework for regaining momentum by learning to neutralize failure through an iterative mindset — treating slip-ups as feedback, making small adjustments, and trying again.You'll also learn behavior strategies to help break bad habits by “putting the brakes” between you and a craving — and why chronic stress can make the habenula more reactive for people stuck in a deeper addiction loop, sometimes requiring layered support.Featuring: Dr. Kyra BobinetAuthor of Unstoppable Brain: The New Neuroscience That Frees Us From Failure, Eases Our Stress, and Creates Lasting Change---If you loved listening to this Live Talk, visit our website to find more of our Alzheimer's coverage and subscribe to our newsletter: https://www.beingpatient.com/Follow Being Patient: Twitter: https://twitter.com/Being_Patient_Instagram: https://www.instagram.com/beingpatientvoices/Facebook: https://www.facebook.com/beingpatientalzheimersLinkedIn: https://www.linkedin.com/company/being-patientBeing Patient is an editorially independent journalism outlet for news and reporting about brain health, cognitive science, and neurodegenerative diseases. In our Live Talk series on Facebook, former Wall Street Journal Editor and founder of Being Patient, Deborah Kan, interviews brain health experts and people living with dementia. Check out our latest Live Talks: https://beingpatient.com/live-talks/

This interview was brought to you in partnership with Eisai and is part of the Journey to Diagnosis series.Eisai: https://www.eisai.com/index.htmlJourney to Diagnosis: https://beingpatient.com/journey-to-diagnosis/Luke Davis spent four decades as a Dallas attorney — and an active husband, father, youth sports coach and school board member — before subtle memory changes raised concerns. In this Being Patient Perspectives interview, Luke and his wife, Paula Davis, share the early signs of Alzheimer's they noticed first, how they pursued answers, and what helped them move forward.After a primary care visit, Luke underwent cognitive testing, an MRI and an amyloid PET scan that confirmed plaque. In April 2023, just before his 69th birthday, he was diagnosed with early-stage Alzheimer's disease. Luke later learned he carries two copies of the APOE4 gene, a major genetic risk factor for Alzheimer's.Luke and Paula also discuss treatment and support — including Luke's experience with Leqembi (lecanemab) infusions — and how they've leaned on the Alzheimer's Association, community, and practical day-to-day strategies. Their message for newly diagnosed individuals and couples: Alzheimer's is a detour, not a dead end — and Luke is focused on “living with Alzheimer's, not dying from it.”Topics covered: early Alzheimer's symptoms, diagnosis journey, amyloid PET scan, APOE4, Leqembi/lecanemab, caregiving as a spouse, coping after diagnosis, living well with Alzheimer's, advocacy and support.#Alzheimers #EarlyAlzheimers #Leqembi #Lecanemab #APOE4 #Dementia #BrainHealth #BeingPatient---- If you loved watching this Live Talk, visit our website to find more of our Alzheimer's coverage and subscribe to our newsletter: https://www.beingpatient.com/Follow Being Patient: Twitter: https://twitter.com/Being_Patient_Instagram: https://www.instagram.com/beingpatientvoices/Facebook: https://www.facebook.com/beingpatientalzheimersLinkedIn: https://www.linkedin.com/company/being-patientBeing Patient is an editorially independent journalism outlet for news and reporting about brain health, cognitive science, and neurodegenerative diseases. In our Live Talk series on Facebook, former Wall Street Journal Editor and founder of Being Patient, Deborah Kan, interviews brain health experts and people living with dementia. Check out our latest Live Talks: https://beingpatient.com/live-talks/

Sende uns Deine NachrichtWarum 2026 kein Technologiejahr wird, sondern ein Jahr der EntscheidungIn dieser Folge geht es um Künstliche Intelligenz jenseits von Hype und Heilsversprechen. Es geht um Verantwortung statt Tools, um Haltung statt Roadmaps und um die Frage, was Führung bedeutet, wenn KI selbstverständlich geworden ist. Ein Ausblick zwischen den Jahren auf ein Möglichkeitsjahr, das weniger Technik verlangt als Mut, Klarheit und menschliche Reife.Support the show________________ Abonniere den Podcast bei Apple oder Spotify und unterstütze uns mit deiner 5-Sterne-Bewertung, damit weitere spannende Gäste unserer Einladung zum Podcast-Interview folgen. Für noch mehr exklusive Inhalte, wie z.B. Videoaufzeichnungen, Live-Talks und zusätzliche Hintergrundinformationen, sowie den Zugang zur Podcast-Community registriere dich kostenfrei auf der Plattform des Bundesverbandes für KI-Transformation e.V.: https://www.venture-ai-germany.space Vernetze dich mit Norman auf LinkedIn https://www.linkedin.com/in/muellernorman

Rod Van Blake, Jocelyn Short, and Jordan Purnell Jackson give their thoughts on the final two episodes of Welcome to Derry season 1! Spoilers if you have yet to watch!

Jocelyn Short, Rod Van Blake, and Jordan Purnell Jackson give their thoughts on episodes 5 and 6 of Welcome to Derry the IT prequel show! Spoilers if you have yet to make it that far!

Jocelyn Short and Rod Van Blake give their thoughts on episodes 3 and 4 of Welcome to Derry! Spoilers if you have yet to watch that far!

Before his Alzheimer's diagnosis, Greg Nelson spent his career as a leadership developer helping others grow. About a year and a half ago, his wife Shasta began to notice changes in his memory and urged him to get evaluated. They went to UC Davis's  Healthy Aging Clinic, where cognitive testing suggested mild cognitive impairment (MCI). A neurologist later ordered a PET scan and by mid-February, Greg had an official Alzheimer's diagnosis.For Greg, who didn't want to retire and loved his work, this set off a shift in identity. Part of adjusting has meant finding a new voice. He now writes candidly about his experience living with Alzheimer's — keeping a blog and sharing posts for his kids, his community, and for others going through similar challenges. Greg says that writing about his experience and connecting with others online has been a game changer, helping him find community and purpose after his diagnosis.In this conversation with Being Patient's Mark Niu, the couple breaks down early signs, from trouble with tracking TV plots to feeling overwhelmed by multi-step instructions. They also share what the diagnostic process can really look like: months-long waits, hours of neuropsychological testing and the importance of establishing a clear baseline. They explain why they chose to be public about Greg's diagnosis — writing blog posts and having candid public conversations to reduce shame, invite support, and help others feel less alone as they navigate Alzheimer's in real time.If you loved listening to this Live Talk, visit our website to find more of our Alzheimer's coverage and subscribe to our newsletter: https://www.beingpatient.com/Follow Being Patient: Twitter:   / being_patient_  Instagram:   / beingpatientvoices  Facebook:   / beingpatientalzheimers  LinkedIn:   / being-patient  Being Patient is an editorially independent journalism outlet for news and reporting about brain health, cognitive science, and neurodegenerative diseases. In our Live Talk series on Facebook, former Wall Street Journal Editor and founder of Being Patient, Deborah Kan, interviews brain health experts and people living with dementia. Check out our latest Live Talks: https://www.beingpatient.com/category...

Jordan Purnell Jackson, Jocelyn Short, and Rod Van Blake discuss the first two episodes of the IT prequel series on HBOmax! Spoilers if you haven't started it!

Dr. Anna Chodos, MPH, is the executive director of Dementia Care Aware, an initiative that helps primary care providers across the country improve dementia detection and care. A professor of medicine at Zuckerberg San Francisco General Hospital and the University of California, San Francisco, her clinical work focuses on outpatient geriatrics and dementia care, and her research centers on the unmet needs of older adults, especially those living with dementia.In conversation with Being Patient's Mark Niu, Chodos breaks down what “cognitive decline” really means, how to tell the difference between normal aging and concerning changes, and which early symptoms should prompt a closer look. She walks through what a basic cognitive assessment in primary care typically involves, offers concrete questions families can bring to appointments, and shares strategies for advocating when concerns are brushed off as “just getting older.”---If you loved listening to this Live Talk, visit our website to find more of our Alzheimer's coverage and subscribe to our newsletter: https://www.beingpatient.com/Follow Being Patient: Twitter: https://twitter.com/Being_Patient_Instagram: https://www.instagram.com/beingpatientvoices/Facebook: https://www.facebook.com/beingpatientalzheimersLinkedIn: https://www.linkedin.com/company/being-patientBeing Patient is an editorially independent journalism outlet for news and reporting about brain health, cognitive science, and neurodegenerative diseases. In our Live Talk series on Facebook, former Wall Street Journal Editor and founder of Being Patient, Deborah Kan, interviews brain health experts and people living with dementia. Check out our latest Live Talks: https://www.beingpatient.com/category/video/

Dr. Anna Chodos, MPH, is the executive director of Dementia Care Aware, an initiative that helps primary care providers across the country improve dementia detection and care. A professor of medicine at Zuckerberg San Francisco General Hospital and the University of California, San Francisco, her clinical work focuses on outpatient geriatrics and dementia care, and her research centers on the unmet needs of older adults, especially those living with dementia.In conversation with Being Patient's Mark Niu, Chodos breaks down what “cognitive decline” really means, how to tell the difference between normal aging and concerning changes, and which early symptoms should prompt a closer look. She walks through what a basic cognitive assessment in primary care typically involves, offers concrete questions families can bring to appointments, and shares strategies for advocating when concerns are brushed off as “just getting older.”If you loved listening to this Live Talk, visit our website to find more of our Alzheimer's coverage and subscribe to our newsletter: https://www.beingpatient.com/Follow Being Patient: Twitter:   / being_patient_  Instagram:   / beingpatientvoices  Facebook:   / beingpatientalzheimers  LinkedIn:   / being-patient  Being Patient is an editorially independent journalism outlet for news and reporting about brain health, cognitive science, and neurodegenerative diseases. In our Live Talk series on Facebook, former Wall Street Journal Editor and founder of Being Patient, Deborah Kan, interviews brain health experts and people living with dementia. Check out our latest Live Talks: https://beingpatient.com/live-talks/

Before his symptoms began, Anthony and Karen Sanone were always on the move, traveling, working and staying active. A former college athlete who played football and baseball, Anthony spent more than 35 years as a chemical sales manager. Karen, a director of human resources at an education agency, now balances her professional role with caregiving. The couple documents their experiences on Anthony's Instagram account, @anthony_vs_alzheimers, and through their younger-onset caregiver community, Surviving the Now.In this conversation with Being Patient's Mark Niu, Anthony and Karen talk about the early warning signs and the long, often confusing road to a younger-onset Alzheimer's diagnosis. They discuss navigating work, pursuing treatment with Leqembi, managing seizures, and reshaping daily life around routines, travel strategies, and safety. Karen also shares candid advice on planning for the future, building a support system and finding ways to “live in the moment” and make meaningful memories, even as the disease progresses.-- If you loved listening to this Live Talk, visit our website to find more of our Alzheimer's coverage and subscribe to our newsletter: https://www.beingpatient.com/Follow Being Patient: Twitter: https://twitter.com/Being_Patient_Instagram: https://www.instagram.com/beingpatientvoices/Facebook: https://www.facebook.com/beingpatientalzheimersLinkedIn: https://www.linkedin.com/company/being-patientBeing Patient is an editorially independent journalism outlet for news and reporting about brain health, cognitive science, and neurodegenerative diseases. In our Live Talk series on Facebook, former Wall Street Journal Editor and founder of Being Patient, Deborah Kan, interviews brain health experts and people living with dementia. Check out our latest Live Talks: https://www.beingpatient.com/category/video/

Rod Van Blake, Jocelyn Short, and Jordan Purnell Jackson give their thoughts on the latest Predator film! Spoilers for those of you who have not seen Predator Badlands!

Rod Van Blake, Jocelyn Short and Jordan Purnell Jackson give their thought on the final two episodes of Splinter Cell Deathwatch! Spoiler alert if you have not finished the series!

Neuroscience has long focused on neurons, but researchers are turning their attention to another kind of brain cell: glial cells. These non-neuronal cells help shape information processing, support brain circuits and influence vulnerability to neurodegenerative diseases — and there are roughly as many glial cells in the human brain as neurons.Terrence Sejnowski, PhD, is a professor and laboratory head of the Computational Neurobiology Laboratory and Francis Crick Chair at the Salk Institute for Biological Studies. In a recent Salk study, he and his team compared glial cell organization across different brain regions and mammal species, finding striking patterns in how these cells are arranged. His work looks at how glial cells differ across brain regions and species, and what those patterns might mean for brain function and disease risk.In this interview, Sejnowski explains the three main types of glial cells and their roles: astrocytes that help feed neurons and support learning and memory, microglia that act like janitors clearing waste and damage, and oligodendrocytes that insulate nerve fibers so signals travel faster. He discusses how glial cells help clean the brain during sleep, how they may be involved early in conditions like Alzheimer's and multiple sclerosis, and why some research suggests glia could be a better marker of brain health than neurons alone. His insights point to a future in which understanding and protecting glial cells could open new paths for prevention and treatment.—-If you loved watching this Live Talk, visit our website to find more of our Alzheimer's coverage and subscribe to our newsletter: https://www.beingpatient.com/Follow Being Patient: Twitter: https://twitter.com/Being_Patient_Instagram: https://www.instagram.com/beingpatientvoices/Facebook: https://www.facebook.com/beingpatientalzheimersLinkedIn: https://www.linkedin.com/company/being-patientBeing Patient is an editorially independent journalism outlet for news and reporting about brain health, cognitive science, and neurodegenerative diseases. In our Live Talk series on Facebook, former Wall Street Journal Editor and founder of Being Patient, Deborah Kan, interviews brain health experts and people living with dementia. Check out our latest Live Talks: https://www.beingpatient.com/category/video/

Jocelyn Short, Rod Van Blake and Jordan Purnell Jackson give their thoughts on the 5th and 6th episodes of Splinter Cell deathwatch! Spoilers if you have yet to watch that far!

Can improving hearing help preserve memory and thinking as we age? Hearing loss isn't just an inconvenience of aging — it's now considered one of the top modifiable risk factors for dementia.Kimberly Mueller, Ph.D., is an associate professor in the Department of Communication Sciences and Disorders at the University of Wisconsin–Madison and a researcher with the Wisconsin Alzheimer's Disease Research Center. Her work focuses on how speech and language change in preclinical Alzheimer's, mild cognitive impairment and dementia. She also leads a clinical trial testing whether over-the-counter hearing aids can benefit people who have mild cognitive impairment and are found to have age-related hearing loss.In this conversation with Being Patient's Mark Niu, Mueller explains why hearing loss is both common and treatable — affecting about one in three adults over 65 — and why it is now considered one of the top modifiable risk factors for dementia. She breaks down how untreated hearing loss can strain the brain, contribute to social isolation and potentially accelerate cognitive decline, and she discusses how new hearing technologies and over-the-counter devices might expand access to care. Mueller also shares early insights from her hearing aid trial, communication strategies for families, and emerging research using everyday speech patterns as a sensitive tool to detect brain changes earlier than standard memory testing.—-If you loved listening to this Live Talk, visit our website to find more of our Alzheimer's coverage and subscribe to our newsletter: https://www.beingpatient.com/Follow Being Patient: Twitter: https://twitter.com/Being_Patient_Instagram: https://www.instagram.com/beingpatientvoices/Facebook: https://www.facebook.com/beingpatientalzheimersLinkedIn: https://www.linkedin.com/company/being-patientBeing Patient is an editorially independent journalism outlet for news and reporting about brain health, cognitive science, and neurodegenerative diseases. In our Live Talk series on Facebook, former Wall Street Journal Editor and founder of Being Patient, Deborah Kan, interviews brain health experts and people living with dementia. Check out our latest Live Talks: https://www.beingpatient.com/category/video/

Jordan Purnell Jackson, Jocelyn Short, and Rod Van Blake give their thoughts on episodes 3 and 4 of Splinter Cell Deathwatch! Spoilers if you have yet to watch that far.

Could AI-driven retinal imaging flag Alzheimer's decades before symptoms start? That question is central to RetiSpec's mission. The health technology company is developing AI-powered retinal imaging to detect Alzheimer's-related biomarkers, like amyloid — by looking at the back of the eye. Catherine Bornbaum, PhD, RetiSpec's chief business officer, says the aim is to make biomarker testing simpler, more scalable, and easier for people to access.In this conversation with Being Patient's founder Deborah Kan, Bornbaum explains how decades of research show that changes in the back of the eye can mirror the structural, functional and molecular changes of Alzheimer's in the brain, making the retina a powerful, noninvasive window for early detection.Bornbaum also describes how AI-driven, real-time analysis of eye images using cameras already in optometrists' offices could make eye exams a practical access point for noninvasive Alzheimer's biomarker testing.—-If you loved listening to this Live Talk, visit our website to find more of our Alzheimer's coverage and subscribe to our newsletter: https://www.beingpatient.com/Follow Being Patient: Twitter: https://twitter.com/Being_Patient_Instagram: https://www.instagram.com/beingpatientvoices/Facebook: https://www.facebook.com/beingpatientalzheimersLinkedIn: https://www.linkedin.com/company/being-patientBeing Patient is an editorially independent journalism outlet for news and reporting about brain health, cognitive science, and neurodegenerative diseases. In our Live Talk series on Facebook, former Wall Street Journal Editor and founder of Being Patient, Deborah Kan, interviews brain health experts and people living with dementia. Check out our latest Live Talks: https://www.beingpatient.com/category/video/

Viitorul muncii: oameni, roboți și sens.Ce se schimbă, ce rămâne și ce mai înseamnă „a munci” într-o lume în care AI-ul nu mai e viitor, ci colegul de birou? E viitorul muncii e despre roboți sau oameni? Sau despre cum vor învăța să lucreze împreună?Încearcă să afle Marian Hurducaș, în această ediție de Upgarde 100 Live Talks, care a avutu loc la Radio Guerrilla. Invitați săi: Raluca Dumitra – Chief Marketing Officer @ eJobs România, specialist în employer branding și cultura organizațională. Andrei Petreanu – AI researcher & community builder, fondator Brain-Waves.ai și RO AI Alliance.Pe lista de întrebări: cum se transformă joburile sub presiunea automatizării, ce competențe vor conta în 2030, cum rămânem umani într-o lume augmentată de algoritmi, și de ce sensul muncii devine noua monedă profesională. O conversație de aproximativ 1,5 ore despre echilibrul dintre eficiență și sens, dintre AI și empatie.Studiul "Student în România. Tânăr în România" poate fi accesat aici.

Rod Van Blake, Jordan Purnell Jackson and Jocelyn Short give their thoughts on the first two episodes of Splinter Cell Deathwatch streaming now on Netflix! SPOILERS!

Parkinson's cases are rising. Dr. Ray Dorsey says our environment is a big reason why. In “The Parkinson's Plan,” Dorsey and co-author Dr. Michael Okun argue that modifiable environmental exposures are fueling the disease, and they outline practical steps to reduce risk and improve treatment.Dorsey is a professor of neurology at the University of Rochester and a public health advocate focused on eliminating toxic exposures linked to neurodegenerative disease. A co-author of “Ending Parkinson's Disease,” he has testified before Congress, advised the World Health Organization and was recognized by the White House as a Champion for Change. He also serves as the founding director of the Center for the Brain & Environment at Atria Health and Research Institute.In this conversation with Being Patient founder Deborah Kan, Dorsey explains why most Parkinson's cases appear to be driven more by environmental chemicals than by genes, and what that means for prevention. He outlines practical steps — from reducing pesticide and solvent exposure to filtering water and air — alongside evidence-backed habits like vigorous exercise and getting specialist care. —-If you loved listening to this Live Talk, visit our website to find more of our Alzheimer's coverage and subscribe to our newsletter: https://www.beingpatient.com/Follow Being Patient: Twitter: https://twitter.com/Being_Patient_Instagram: https://www.instagram.com/beingpatientvoices/Facebook: https://www.facebook.com/beingpatientalzheimersLinkedIn: https://www.linkedin.com/company/being-patientBeing Patient is an editorially independent journalism outlet for news and reporting about brain health, cognitive science, and neurodegenerative diseases. In our Live Talk series on Facebook, former Wall Street Journal Editor and founder of Being Patient, Deborah Kan, interviews brain health experts and people living with dementia. Check out our latest Live Talks: https://www.beingpatient.com/category/video/

In our latest “Ask Teepa Anything” Live Talk, dementia care expert Teepa Snow answers caregivers' real-world questions — from safe ways to help a person up after a fall to medication trade-offs, late-stage planning, and day-to-day communication.Snow is an occupational therapist with more than 40 years of clinical and academic experience. She developed the GEMS States of Brain Change and the Positive Approach training strategies, founded Positive Approach to Care, and co-founded the Snow Approach Foundation in Hillsborough, North Carolina. —-If you loved listening to this Live Talk, visit our website to find more of our Alzheimer's coverage and subscribe to our newsletter: https://www.beingpatient.com/Follow Being Patient: Twitter: https://twitter.com/Being_Patient_Instagram: https://www.instagram.com/beingpatientvoices/Facebook: https://www.facebook.com/beingpatientalzheimersLinkedIn: https://www.linkedin.com/company/being-patientBeing Patient is an editorially independent journalism outlet for news and reporting about brain health, cognitive science, and neurodegenerative diseases. In our Live Talk series on Facebook, former Wall Street Journal Editor and founder of Being Patient, Deborah Kan, interviews brain health experts and people living with dementia. Check out our latest Live Talks: https://www.beingpatient.com/category/video/

Dr. Laura Baker, PhD, is a professor of gerontology and geriatric medicine at Wake Forest University School of Medicine and the principal investigator of the U.S. POINTER study, a large, Alzheimer's Association–backed trial inspired by Finland's landmark FINGER study. Designed to test whether lifestyle can protect brain health in a diverse U.S. population, POINTER enrolled 2,111 adults ages 60 to 79 across five regions. Participants who were not already exercising or eating a Mediterranean-style diet engaged in lifestyle changes across four pillars: physical activity, nutrition, cognitive and social engagement, and tracking health numbers like blood pressure and blood sugar.In this interview with Being Patient's Mark Niu, Baker traces how POINTER was designed, what a coach-supported lifestyle program looks like in practice, and why community partners matter. She also previews what's ahead — from brain imaging to sleep and vascular findings — and offers practical guidance for caregivers and older adults.—-If you loved listening this Live Talk, visit our website to find more of our Alzheimer's coverage and subscribe to our newsletter: https://www.beingpatient.com/Follow Being Patient: Twitter: https://twitter.com/Being_Patient_Instagram: https://www.instagram.com/beingpatientvoices/Facebook: https://www.facebook.com/beingpatientalzheimersLinkedIn: https://www.linkedin.com/company/being-patientBeing Patient is an editorially independent journalism outlet for news and reporting about brain health, cognitive science, and neurodegenerative diseases. In our Live Talk series on Facebook, former Wall Street Journal Editor and founder of Being Patient, Deborah Kan, interviews brain health experts and people living with dementia. Check out our latest Live Talks: https://www.beingpatient.com/category/video/

Originally from Argentina, educator and creative entrepreneur Laura Tobi, 58, moved to the U.S. 26 years ago. An educational designer by training, she has worked with labor unions, corporations, government, and public and private school systems, later founding a Miami-based business to cultivate creative thinking for learners of all ages. After years as a caregiver to her both husband and daughter through serious chronic illnesses, she and her husband relocated to North Carolina in 2024, where she noticed increased memory problems. A neurologist connected the dots: a lumbar puncture confirmed Alzheimer's, and further evaluation found epilepsy, revealing silent seizures. In this interview with Being Patient's Mark Niu, Tobi shares how she pairs Leqembi infusions with lifestyle changes inspired by the Ornish program — nutrition, exercise, stress management, and social support — while staying rooted in community through volunteering, teaching, improv, and clay sculpture in her home studio. Her takeaways: build community, stay mentally and physically active, advocate for yourself, and keep seeking joy — through teaching, volunteering, improv, and making art.—-If you loved listening to this Live Talk, visit our website to find more of our Alzheimer's coverage and subscribe to our newsletter: https://www.beingpatient.com/Follow Being Patient: Twitter: https://twitter.com/Being_Patient_Instagram: https://www.instagram.com/beingpatientvoices/Facebook: https://www.facebook.com/beingpatientalzheimersLinkedIn: https://www.linkedin.com/company/being-patientBeing Patient is an editorially independent journalism outlet for news and reporting about brain health, cognitive science, and neurodegenerative diseases. In our Live Talk series on Facebook, former Wall Street Journal Editor and founder of Being Patient, Deborah Kan, interviews brain health experts and people living with dementia. Check out our latest Live Talks: https://www.beingpatient.com/category/video/

Rod Van Blake Jocelyn Short and Jordan Purnell Jackson give their thoughts on the eighth and final episode of Alien Earth season 1! Spoilers if you have yet to finish it!

In recovery, complacency can sneak up on us — and it's one of the biggest threats to long-term sobriety. In this live session, I'll share what complacency looks like, how to recognize the warning signs, and practical ways to keep your recovery fresh and active every day. Whether you're new to sobriety or have been trudging the road for years, this talk will give you honest insights and motivation to stay engaged, accountable, and moving forward one day at a time.

Scientists are still searching for effective treatments for neurodegenerative disorders like Alzheimer's, ALS, and chronic traumatic encephalopathy (CTE). In his pioneering research, neurosurgeon Dr. Christopher Duma is testing whether stem cell therapy can effectively treat these diseases. Duma is medical director of Hoag Memorial Presbyterian Hospital's Brain Tumor Program in Newport Beach, California and president and founder of Regeneration Biomedical, which develops stem cell therapies for neurological disorders. He recently completed Phase 1 of its clinical trial, a first-in-human approach that delivers a patient's own fat-derived stem cells directly into the brain's ventricles to target neurodegenerative diseases.In this interview with Being Patient's Mark Niu, Duma discusses how the trial is progressing. He explains the approach, shares Phase 1 safety results with encouraging early signals in biomarkers and cognition, and outlines a Phase 2 trial that will test effectiveness in a larger group of participants with mild to moderate Alzheimer's disease. Phase 2 of the study calls for injections every two months with regular scans and laboratory tests, aiming to show whether this therapy could expand care options for people living with neurodegenerative disease.—-If you loved listening to this Live Talk, visit our website to find more of our Alzheimer's coverage and subscribe to our newsletter: https://www.beingpatient.com/Follow Being Patient: Twitter: https://twitter.com/Being_Patient_Instagram: https://www.instagram.com/beingpatientvoices/Facebook: https://www.facebook.com/beingpatientalzheimersLinkedIn: https://www.linkedin.com/company/being-patientBeing Patient is an editorially independent journalism outlet for news and reporting about brain health, cognitive science, and neurodegenerative diseases. In our Live Talk series on Facebook, former Wall Street Journal Editor and founder of Being Patient, Deborah Kan, interviews brain health experts and people living with dementia. Check out our latest Live Talks: https://www.beingpatient.com/category/video/

In today's Daily Trudge Live, I'm talking about “Be Accountable or Go Back to the Bottle.” Accountability isn't just a buzzword — it's one of the core practices that keeps us sober and growing. In this episode, I share what accountability looks like in real life, why avoiding it can send us back to old habits, and practical ways to build it into your recovery today. Whether you're new to sobriety or years in, this live session will give you honest insights and tools to help you stay on track — one day at a time.

Jordan Purnell Jackson, Rod Van Blake and Jocelyn Short talk Alien Earth episode 7! Spoilers if you have yet to watch that far!

U.S. Navy veteran Chris Tann, was diagnosed with behavioral variant frontotemporal dementia in 2019 after his wife, Debra, noticed behavioral changes and began documenting unusual incidents at home. They began learning and raising awareness about a condition that is often misunderstood. Today, he is an active member of the Black Dementia Minds support group and a participant in a long-term clinical trial at Vanderbilt University.In this conversation with Being Patient's founder Deborah Kan, the couple discuss the early signs Chris exhibited prior to his diagnosis, the behavioral changes that come with behavioral variant frontotemporal dementia, caregiving strategies, and how faith plays a central role in how Chris copes with his diagnosis. Together, they emphasize the importance of awareness, advocacy, and research participation.—-If you loved listening to this Live Talk, visit our website to find more of our Alzheimer's coverage and subscribe to our newsletter: https://www.beingpatient.com/Follow Being Patient: Twitter: https://twitter.com/Being_Patient_Instagram: https://www.instagram.com/beingpatientvoices/Facebook: https://www.facebook.com/beingpatientalzheimersLinkedIn: https://www.linkedin.com/company/being-patientBeing Patient is an editorially independent journalism outlet for news and reporting about brain health, cognitive science, and neurodegenerative diseases. In our Live Talk series on Facebook, former Wall Street Journal Editor and founder of Being Patient, Deborah Kan, interviews brain health experts and people living with dementia. Check out our latest Live Talks: https://www.beingpatient.com/category/video/

Jordan Purnell Jackson and Rod Van Blake discuss the sixth episode of Alien Earth streaming now on Disney plus/Hulu! Spoilers if you have yet to watch that far!

Der "Ehlers-Rhetorik-Podcast" Seit Juli 2008 bereits DER TOP RHETORIK PODCAST! Der Podcast mit hilfreichen, wichtigen und interessanten Informationen rund um professionelle Kommunikation mit dem Rhetoriktrainer der Top-Manager, Politiker und Persönlichkeiten des öffentlichen Lebens: Michael Ehlers. Regelmäßige LIVE Talks mit den besten Expert*innen aus der DACH-Region zum Thema Rhetorik! Ein Muss für alle, die mit ihren Worten etwas bewegen wollen. "Wer etwas zu sagen hat, sollte reden können" Infos zu und Vernetzung MIT Michael Ehlers: www.Heldengeschichten.de

Rod Van Blake, Jocelyn Short and Jordan Purnell Jackson discuss episode 5 of Alien Earth streaming now in Disney plus/HULU! Spoilers if you have not watched that far!

In hour 4, the WIP Midday Show are joined by Boxer and former Undisputed Heavyweight Champion of the World, Mike Tyson! Plus, guessing the main takeaways from this weekend in the NFL, making a parlay for Eagles vs Chiefs and You People.

Missed RealWorld 2025? Don’t worry—we’ve got the highlights covered! Join us for the next Multifamily Talks Live session, where Krista Hurley, Industry Principal at RealPage®, will team up with two multifamily operators to unpack the biggest takeaways from this year’s RealWorld conference. From groundbreaking AI advancements to actionable strategies and innovative solutions, this session will arm you with the insights you need to stay ahead in the multifamily industry. What you’ll gain: Key trends shaping the future of multifamily Actionable insights from industry leaders How to leverage innovation to elevate your business Don’t miss this chance to learn, connect and lead the conversation in multifamily innovation. Connect with Dennis and Krista on LinkedIn for more expert insights!

Missed RealWorld 2025? Don’t worry—we’ve got the highlights covered! Join us for the next Multifamily Talks Live session, where Krista Hurley, Industry Principal at RealPage®, will team up with two multifamily operators to unpack the biggest takeaways from this year’s RealWorld conference. From groundbreaking AI advancements to actionable strategies and innovative solutions, this session will arm you with the insights you need to stay ahead in the multifamily industry. What you’ll gain: Key trends shaping the future of multifamily Actionable insights from industry leaders How to leverage innovation to elevate your business Don’t miss this chance to learn, connect and lead the conversation in multifamily innovation. Connect with Krista on LinkedIn for more expert insights!

What does it feel like to take part in the largest lifestyle intervention trial in the United States?In this conversation, Patty Kelly and Phyllis Jones share personal stories about how Alzheimer's disease has shaped their families — and why they chose to get involved in groundbreaking research aimed at preventing or slowing cognitive decline.If you loved this video, visit our website to find more of our Alzheimer's coverage and subscribe to our newsletter: https://www.beingpatient.com/Follow Being Patient: Twitter: https://twitter.com/Being_Patient_Instagram: https://www.instagram.com/beingpatientvoices/Facebook: https://www.facebook.com/beingpatientalzheimersLinkedIn: https://www.linkedin.com/company/being-patientBeing Patient is an editorially independent journalism outlet for news and reporting about brain health, cognitive science, and neurodegenerative diseases. In our Live Talk series on Facebook, former Wall Street Journal Editor and founder of Being Patient, Deborah Kan, interviews brain health experts and people living with dementia. Check out our latest Live Talks: https://www.beingpatient.com/category/video/

Jocelyn Short, Jordan Purnell Jackson, and Rod Van Blake give their thoughts on the Fantastic Four's first official outing in the MCU! Spoilers if you have yet to see it!

Jocelyn Short, and Rod Van Blake discuss K-Pop Demon Hunters streaming now on Netflix! Spoilers for those who have yet to see it!

⁠Rod Van Blake ⁠and Jocelyn Short talk the first 3 episodes of Iron Heart! Spoilers if you haven't watched that far!

Governor Healy joins the show live!